Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride rescue treatment for postoperative nausea and vomiting after metabolic surgery in obese adults
ChiCTR2600131940Phase 4Not yet recruiting
- Sponsor
- Nanning Second People's Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amisulpride in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Nanning Second People's Hospital. Primary endpoint: 24-hour complete response rate. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
amisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600131940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131940.